Latest filing published 20 Oct 2026 for Kintor Pharmaceutical Ltd. - B, €17k.
Based on 55 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tong Youzhi is a declared insider of Kintor Pharmaceutical Ltd. - B (chief executive), with filings sourced from HKEX. The record holds 71 filings, for trades running from 22 May 2020 to 16 October 2026.
The open-market side counts 61 purchases for €111.2M alongside 7 sales for €143.1M. No amount is published for 4 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 25 purchases and no sales.
The median purchase comes to €31k. Measured against the company's value, the median purchase equals 0.023% of market capitalisation, across 20 purchases where it is known. No cluster: in 58 purchases, no other insider of the company bought within 30 days. Looking at 55 purchases old enough to measure, the stock rose over the following 90 days in 25% of cases; the median change was -17.4%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 20 October 2026 with an open-market purchase (€17k) in Kintor Pharmaceutical Ltd. - B. The median gap between a trade and its publication by HKEX is 1 day. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 71 declarations